Announcements Trials
Browse Landscape

Phase

Phase 2 65Phase 3 38Phase NA 21Phase 2/3 7Phase 1 6Phase 1/2 5Phase 4 4Phase EARLY_PHASE1 1

Status

Active not recruiting 3Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 4Urogenital Neoplasms 1Radiation Injuries 1Prostatic Diseases 1Genital Neoplasms, Male 1Adenocarcinoma of the Prostate 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Androgen Antagonists × Clear all
NCT05067140 2026-05-05

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Novartis

Phase 1/2 Active not recruiting
152 enrolled
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Active not recruiting
44 enrolled
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

NCT01517451 2026-02-11

Radiation and Androgen Ablation for Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
45 enrolled 11 charts
Genitourinary

Adenocarcinoma of the Prostate

NCT04737109 2023-11-13

ADDItion

Big Ten Cancer Research Consortium

Phase 1/2 Terminated
6 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT05003752 2023-03-07

Hypo-Combi

German Oncology Center, Cyprus

Phase 1/2 Active not recruiting
40 enrolled
Genitourinary

Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡